Gene · 5928
Papers2,308
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,308
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Poliovirus receptor (PVR) expression as a predictor of relapse in colorectal cancer: bioinformatics and virtual screening. | Exp Biol Med (Maywood) | 2026 | 41767749 | PubTator, text mining | PubMed |
| Intratumoral heterogeneity in microsatellite instability status at single-cell resolution. | iScience | 2026 | 41767255 | PubTator, text mining | PubMed |
| Mismatch Repair Protein and Microsatellite Instability Analysis in Pancreatic Ductal Adenocarcinoma. | J Clin Med | 2026 | 41753099 | PubTator, text mining | PubMed |
| Analysis of Consensus Molecular Subtypes of Colorectal Cancer in Oman with Clinicopathologic Correlation. | Int J Mol Sci | 2026 | 41752172 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Mechanisms in Serrated Adenocarcinomas and Classical Colorectal Carcinomas: An In Silico Study. | Curr Issues Mol Biol | 2026 | 41751442 | PubTator, text mining | PubMed |
| Major Advances in Gynecologic Oncology in 2025: Systematic Review and Synthesis of Conference and Published Evidence. | Biomedicines | 2026 | 41751194 | PubTator, text mining | PubMed |
| The Development of Novel Treatment Strategies for Rhabdomyosarcoma. | Cancers (Basel) | 2026 | 41749943 | PubTator, text mining | PubMed |
| Integrated Molecular Profiling of Colorectal Cancer by Tumor Location: Evidence from a Real-World Cohort with Primary and Metastatic Samples. | Cancers (Basel) | 2026 | 41749919 | PubTator, text mining | PubMed |
| Selective Benefit of Adjuvant Chemotherapy in Stage II dMMR Colon Cancer with High-Risk Features or Poorly Differentiated Histology: A Retrospective Study. | Cancers (Basel) | 2026 | 41749882 | PubTator, text mining | PubMed |
| [A Case of MSI‒High Advanced or Recurrent Gastric Cancer Showed Complete Response to Pembrolizumab as Third‒Line Treatment]. | Gan To Kagaku Ryoho | 2026 | 41748522 | PubTator, text mining | PubMed |
| Molecular-Guided Precision Oncology in Cancer of Unknown Primary: A State-of-the-Art Perspective. | J Pers Med | 2026 | 41745373 | PubTator, text mining | PubMed |
| Translating Gastric Cancer Genomics into Targeted Therapy: Mechanistic Insights from Animal Models and Patient-Derived Systems. | Cells | 2026 | 41744808 | PubTator, text mining | PubMed |
| Genomic and immunological differences in endometrial cancer: a comparative study between young and old Asian patients. | Front Immunol | 2026 | 41743739 | PubTator, text mining | PubMed |
| Clinicopathologic, genetic and immune cell infiltration analysis of colorectal signet ring cell carcinoma with comparison to conventional adenocarcinoma. | J Natl Cancer Cent | 2026 | 41738041 | PubTator, text mining | PubMed |
| Role of uridine phosphorylase 1 in cancer: A comprehensive pan-cancer analysis highlighting its prognostic and therapeutic potential. | Medicine (Baltimore) | 2026 | 41731765 | PubTator, text mining | PubMed |
| Aggressive Right-Sided Colon Cancer in a Young Adult: Triple-Whammy Mutations (POLE, KRAS, BRCA1/2) Highlight Emerging Genetic Associations. | ACG Case Rep J | 2026 | 41728249 | PubTator, text mining | PubMed |
| Harnessing Anoikis-Related Gene Signatures for Immunotherapy Precision: A Machine Learning-Driven Predictive and Prognostic Model. | ACS Omega | 2026 | 41726702 | PubTator, text mining | PubMed |
| Interoceptive predictors of daily functioning in aging and their interaction with exteroceptive bodily representations. | Front Psychol | 2026 | 41725653 | PubTator, text mining | PubMed |
| The Bioinformatics and Experimental Analysis of CD276 for Prognosis and Immune Infiltrates in Colon Adenocarcinoma. | Cancer Rep (Hoboken) | 2026 | 41725032 | PubTator, text mining | PubMed |
| AI-driven radiogenomics in gynecologic oncology: from radiological digital biopsy to a new paradigm in precision therapy. | Front Oncol | 2026 | 41717418 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5928/papers?page=4